Agreed, getting an independent valuation is normal practice during negotiations. As is calling in specialist advisors, this has been alluded to earlier in the year .
Im confidant the BOD has the expertise or access to it, to bring about a favable result.
Cheers
PAA, A New Dawn , FDA ODD Approval and Entering Phase II MND Trial, page-922
-
- There are more pages in this discussion • 12 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PAA (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
21.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $93.45M | |||
| Open | High | Low | Value | Volume |
| 21.0¢ | 21.5¢ | 20.5¢ | $41.27K | 196.7K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 8 | 132363 | 20.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 21.0¢ | 21931 | 1 |
View Market Depth
| Last trade - 16.10pm 23/07/2024 (20 minute delay) ? |
| PAA (ASX) Chart |